Enthusiasm for its weight loss medications is intensifying, and several companies are preparing oral formulations.

Eli Lilly launches Mounjaro KwikPen in India, offering adults with type 2 diabetes and obesity a once-weekly, ...

Eli Lilly has released Mounjaro KwikPen, a prefilled weekly treatment for type 2 diabetes and obesity in India ...

Eli Lilly introduces its Mounjaro Kwikpen in India at ₹14,000 for the 2.5 mg starting dose, competing with Novo Nordisk’s Wegovy in the booming GLP-1 drug market for diabetes and weight loss.